| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Methylphenidate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Focalin 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Doxapram hydrochloride 20mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 10mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 27mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 54mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 2 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and caffeine and cinnamedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing methylphenidate hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and caffeine and orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing caffeine and paracetamol and salicylamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing buffered aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Ergotamine + caffeine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 72mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Psychostimulant (substance) |
Is a |
True |
Stimulant (substance) |
Inferred relationship |
Some |
|
| Stimulant dependence |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Stimulant drug therapy for attention deficit hyperactivity disorder |
Direct substance |
True |
Stimulant (substance) |
Inferred relationship |
Some |
3 |
| Stimulant therapy |
Direct substance |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Harmful pattern of use of stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Disorder caused by stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Delirium caused by stimulant |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Psychotic disorder caused by stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Mood disorder caused by stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Anxiety disorder caused by stimulant |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Sleep disorder caused by stimulant |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Impulse control disorder caused by stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Sexual dysfunction caused by stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
2 |
| Psychotic disorder with hallucinations caused by stimulant |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Intoxication caused by stimulant (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Episode of harmful use of stimulant |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user. |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
| Sleep disorder due to stimulant dependence (disorder) |
Causative agent (attribute) |
True |
Stimulant (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]